Cyanovirin-N ( CV-N) is a protein produced by the cyanobacterium Nostoc ellipsosporum that displays Virucide activity against several , including human immunodeficiency virus (HIV).[
]
/ref> The virucidal activity of CV-N is mediated through specific high-affinity interactions with the viral Viral envelope Glycoprotein gp120 and gp41, as well as high-mannose found on the HIV envelope. In addition, CV-N is active against , human parainfluenza virus, respiratory syncytial virus, and Enterovirus. The virucidal activity of CV-N against Orthomyxoviridae is directed towards viral haemagglutinin.
The blue-green alga Nostoc ellipsosporum naturally contains CV-N. The National Cancer Institute (NCI) in the United States of America carried out the initial isolation and characterization of this protein in 1999. The use of CV-N as an antiviral drug, particularly against HIV, has since been the subject of investigation. Its ability to bind to the HIV-encapsulating glycoprotein gp120 has been demonstrated in several studies, which has led to the development of CV-N-based Therapy and preventatives.[
]
Structure
CV-N is a lengthy, mostly Beta sheet protein that displays internal two-fold pseudosymmetry. The fundamental atomic root-mean-square of the two sequence repeats (1-50 and 51-101) differs by 1.3 Angstrom while sharing 32% of the same sequence. The total fold depends on a number of interactions between the two repetitions; therefore, they do not actually belong in separate domains. CV-N has a complex fold of a tandem repeat duplication of two homologous Structural motif, comprising three-stranded beta-sheet and Beta hairpin.
External links